Because ovarian clear cell carcinoma is relatively rare, the signals from the patient's specimens were compared with a reference cohort of 19 breast carcinomas (a mixture of hormone receptor–positive/HER2-negative, HER2-positive, and triple-negative). The gene discussed is NR4A1; the disease is ovarian clear cell cancer.